Search

everythinglearnresearchcommunity

for

Search:↓

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

Antiandrogen therapy, like cyproterone acetate, effectively treats acne, hirsutism, and hair loss.

Finasteride's molecular properties and active sites were identified using computational methods.

17b-Estradiol in skin affects hair growth and tumor promotion.

Anabolic-androgenic steroids are dangerous and educating people about their risks is essential.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

GI197111X is best dissolved in Capmul MCM for trials.

A new method effectively predicts estrogen-related health effects for early screening.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Method B with propylene glycol is better for stable low-concentration DPCP solutions for alopecia areata.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

A new molecule was found to be a safe and effective skin lightener and anti-aging product.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

Diphlorethohydroxycarmalol may help treat hair loss better than current medications.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Modified pep7, named EPM peptide, effectively promotes hair growth at low concentrations and works well with minoxidil.

Testosterone and letrozole treatment speeds up puberty in boys with delayed development.

Levamisole and finasteride can reduce DHT production, potentially preventing phenytoin-induced gum overgrowth.

Tiny lipid particles loaded with a hormone gather in hair follicles, which may help treat hair loss.

Androgen levels do not determine the type of PCOS symptoms in young females.